thyroxine has been researched along with Endothelioma, Vascular in 9 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Consumptive hypothyroidism due to cutaneous hemangioma and hepatic hemangioendothelioma can be managed with propranolol and low-dose sirolimus." | 4.12 | Severe consumptive hypothyroidism in hepatic hemangioendothelioma. ( Dubinski, I; Häberle, B; Küppers, J; Lurz, E; Schmid, I; Schmidt, H; Walther, A, 2022) |
| " A 28-day-old boy with TSH level of 77 mIU/mL on neonatal screening and diagnosed as congenital hypothyroidism was started on L-thyroxine (L-T4) (11 μg/kg/day) therapy on the 21(th) day of life." | 3.76 | Hypothyroidism due to hepatic hemangioendothelioma: a case report. ( Ağladioğlu, SY; Aycan, Z; Baş, VN; Bozkurt, C; Çetinkaya, S; Kendirci, HN; Özdemir, S, 2010) |
| "The patient has hypoxemia due to abdominal distention during the follow-up period." | 1.46 | Beta blocker and steroid therapy in the treatment of infantile hepatic hemangioendothelioma. ( Bör, Ö; Düzenli Kar, Y; Kebapçı, M; Özdemir, ZC; Şöhret, NC, 2017) |
| "Liver hemangioendotheliomas are capable of producing an excess of the thyroid hormone inactivating enzyme, type-3 iodothyronine deiodinase." | 1.34 | Rapid resolution of consumptive hypothyroidism in a child with hepatic hemangioendothelioma following liver transplantation. ( Athanassaki, I; Balazs, AE; Gunn, SK; Haymond, MW; Huang, SA; Karaviti, LP; Tatevian, N, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Walther, A | 1 |
| Häberle, B | 1 |
| Küppers, J | 1 |
| Lurz, E | 1 |
| Schmid, I | 1 |
| Schmidt, H | 1 |
| Dubinski, I | 1 |
| Özdemir, ZC | 1 |
| Düzenli Kar, Y | 1 |
| Şöhret, NC | 1 |
| Kebapçı, M | 1 |
| Bör, Ö | 1 |
| Mouat, F | 1 |
| Evans, HM | 1 |
| Cutfield, WS | 1 |
| Hofman, PL | 1 |
| Jefferies, C | 1 |
| Çetinkaya, S | 1 |
| Kendirci, HN | 1 |
| Ağladioğlu, SY | 1 |
| Baş, VN | 1 |
| Özdemir, S | 1 |
| Bozkurt, C | 1 |
| Aycan, Z | 1 |
| Avagyan, S | 1 |
| Klein, M | 1 |
| Kerkar, N | 1 |
| Demattia, A | 1 |
| Blei, F | 1 |
| Lee, S | 1 |
| Rosenberg, HK | 1 |
| Arnon, R | 1 |
| Kalpatthi, R | 1 |
| Germak, J | 1 |
| Mizelle, K | 1 |
| Yeager, N | 1 |
| Balazs, AE | 1 |
| Athanassaki, I | 1 |
| Gunn, SK | 1 |
| Tatevian, N | 1 |
| Huang, SA | 1 |
| Haymond, MW | 1 |
| Karaviti, LP | 1 |
| Ayling, RM | 1 |
| Davenport, M | 1 |
| Hadzic, N | 1 |
| Metcalfe, R | 1 |
| Buchanan, CR | 1 |
| Howard, ER | 1 |
| Mieli-Vergani, G | 1 |
| Spaulding, SW | 1 |
| Burrow, GN | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Sirolimus in the Treatment for Propranolol-resistant Infantile Hepatic Hemangioendothelioma[NCT04406870] | Phase 4 | 36 participants (Anticipated) | Interventional | 2020-07-31 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
9 other studies available for thyroxine and Endothelioma, Vascular
| Article | Year |
|---|---|
Severe consumptive hypothyroidism in hepatic hemangioendothelioma.
Topics: Hemangioendothelioma; Humans; Hypothyroidism; Infant; Liver Neoplasms; Male; Propranolol; Sirolimus; | 2022 |
Beta blocker and steroid therapy in the treatment of infantile hepatic hemangioendothelioma.
Topics: Adrenergic beta-Antagonists; Glucocorticoids; Hemangioendothelioma; Hepatomegaly; Humans; Hypothyroi | 2017 |
Massive hepatic hemangioendothelioma and consumptive hypothyroidism.
Topics: Congenital Hypothyroidism; Female; Hemangioendothelioma; Hepatomegaly; Humans; Infant, Newborn; Live | 2008 |
Hypothyroidism due to hepatic hemangioendothelioma: a case report.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Congenital Hypothyroidism; Hemangioendothelioma; Ho | 2010 |
Propranolol as a first-line treatment for diffuse infantile hepatic hemangioendothelioma.
Topics: Adrenergic beta-2 Receptor Antagonists; Antineoplastic Agents; Congenital Hypothyroidism; Drug Monit | 2013 |
Thyroid abnormalities in infantile hepatic hemangioendothelioma.
Topics: Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Follow-Up Studies; | 2007 |
Rapid resolution of consumptive hypothyroidism in a child with hepatic hemangioendothelioma following liver transplantation.
Topics: Female; Hemangioendothelioma; Humans; Hypothyroidism; Infant; Liver Neoplasms; Liver Transplantation | 2007 |
Hepatic hemangioendothelioma associated with production of humoral thyrotropin-like factor.
Topics: Female; Hemangioendothelioma; Humans; Immunohistochemistry; Infant; Infant, Newborn; Liver Neoplasms | 2001 |
Hemangioendothelioma of the thyroid and concurrent hyperthyroidism.
Topics: Adult; Female; Goiter, Nodular; Hemangioendothelioma; Humans; Hyperthyroidism; Radionuclide Imaging; | 1974 |